Drugs / Δ⁹-tetrahydrocannabinol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01041170 | Apr 2006 → Jan 2010 | cannabis dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Δ⁹-tetrahydrocannabinol | “Ten male daily cannabis smokers received 8 days of increasingly frequent 20-mg oral Δ⁹-tetrahydrocannabinol (THC) dosages (40-120 mg/d) around-the-clock to standardize cannabis...” PMID 21869692 ↗ Oct 2011 |
| Known as | THC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01041170 ↗ |
| Route | Oral | “oral Δ⁹-tetrahydrocannabinol (THC) dosages” PMID 21869692 ↗ Oct 2011 |